Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1875558 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $23.33 · Day +11.57% · Mkt cap $681M · 1Y +280.0% · Off 52W high −20.3% · Vol (1Y) 84.9% Price2023-08-21 → 2026-08-19 NVCT close: $14.9 on 2023-08-21 to $23.3 on 2026-08-19. Split-adj closes · 240 of 1,133 · price returnⓘ At a glance | Short interest5.7% of sh out | | Days to cover7.4d | | 13F net flow (QoQ)+0.29% | | Top-10 13F concentration83.6% | | Next report (est.)2026-11-03 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$27.8M | | ROE−188.0% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+209.0% | | 1Y+280.0% | | 3Y+56.4% | | Since incept. (ann.)+54.4% |
Total return · from 2022-02-04ⓘ Risk | Ann. volatility (1Y)84.9% | | Ann. volatility (3Y)87.3% | | Sharpe (1Y)1.97 | | Sharpe (3Y)0.62 | | Max drawdown (1Y)−36.8% | | Max drawdown (3Y)−69.7% | | Beta (3Y vs SPY)−0.61 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 764,441 | $6M | 2.89% | −2.3% | | VANGUARD CAPITAL MANAGEMENT LLC | 659,879 | $5M | 2.49% | new | | IRIDIAN ASSET MANAGEMENT LLC/CT | 651,757 | $5M | 2.46% | +11.2% | | Occam Crest Management LP | 407,147 | $3M | 1.54% | +7.1% | | GEODE CAPITAL MANAGEMENT, LLC | 384,105 | $3M | 1.45% | +5.5% | | BALDWIN WEALTH PARTNERS LLC/MA | 378,625 | $3M | 1.43% | −2.8% | | STATE STREET CORP | 166,516 | $1M | 0.63% | +7.7% | | NORTHERN TRUST CORP | 124,212 | $960,159 | 0.47% | +6.7% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-04 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-04 | −$0.30 | — | — | — | | 2026-03-31 | 2026-05-05 | −$0.26 | — | — | — | | 2025-09-30 | 2025-11-04 | −$0.44 | — | — | — | | 2025-06-30 | 2025-08-05 | −$0.30 | — | — | — |
As-reported XBRL · next 2026-11-03 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
